Atlas Trials

Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer

Clinical trial NCT02089854 · UNKNOWN

Trial details

NCT number
NCT02089854
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Female Breast Cancer
Start date
2014-11-01
Primary completion
2019-04-01
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.